BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2262977)

  • 1. [A case of nephrotic syndrome with abnormally high level of protein C induced by prednisolone].
    Sakata T; Katayama Y; Matsuyama T; Hatanaka K
    Rinsho Byori; 1990 Oct; 38(10):1198-200. PubMed ID: 2262977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Natural coagulation inhibitors; antithrombin III, protein C, protein S in children with hypercoagulation due to nephrotic syndrome].
    Wygledowska G; Grygalewicz J; Matuszewska E
    Med Wieku Rozwoj; 2001; 5(4):377-88. PubMed ID: 12004145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the protein C-protein S system in glomerulopathies and nephrotic syndrome].
    Rostoker G; Gouault-Heilmann M; Levent M; Lang P; Robeva R; Lagrue G
    Nouv Rev Fr Hematol (1978); 1986; 28(6):359-63. PubMed ID: 2951650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal function after prednisolone treatment in childhood nephrotic syndrome.
    Sumboonnanonda A; Vongjirad A; Suntornpoch V; Petrarat S
    J Med Assoc Thai; 1994 Mar; 77(3):126-9. PubMed ID: 7798846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of linear growth of body height in children with nephrotic syndrome.
    Hung YT; Yang LY
    J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
    Shibasaki H; Nakayama H; Furuta T; Kasuya Y; Tsuchiya M; Soejima A; Yamada A; Nagasawa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):164-9. PubMed ID: 18387858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA; Moia M; Rivolta E; Ponticelli C; Mannucci PM
    Thromb Haemost; 1999 Sep; 82(3):1020-3. PubMed ID: 10494757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-induced osteonecrosis of the femoral condyle in a pediatric patient with nephrotic syndrome.
    Sakai H; Okuda H; Yajima H; Tamai K; Saotome K
    J Knee Surg; 2002; 15(1):41-3. PubMed ID: 11829333
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive study on platelet function, hemostasis, fibrinolysis, peripheral serotonergic system and serum lipids in nephrotic syndrome.
    Małyszko J; Małyszko JS; Pawlak D; Pawlak K; Rydzewski A; Myśliwiec M; Buczko W
    Pol J Pharmacol; 1996; 48(2):191-5. PubMed ID: 9112650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C and renal pathology in Ivory Coast population.
    Blavy G; Koffi D
    Nouv Rev Fr Hematol (1978); 1991; 33(5):359-61. PubMed ID: 1666429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity.
    Kano K; Yamada Y; Shiraiwa T; Shimizu A; Nishikura K; Arisaka O; Tomita S; Ueda Y
    Nephrology (Carlton); 2004 Dec; 9(6):414-7. PubMed ID: 15663646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T; Shalev H; Landau D; Dvilansky A
    Sangre (Barc); 1996 Apr; 41(2):155-7. PubMed ID: 9045358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of plasma protein C in nephrotic syndrome.
    Pabinger-Fasching I; Lechner K; Niessner H; Schmidt P; Balzar E; Mannhalter C
    Thromb Haemost; 1985 Feb; 53(1):5-7. PubMed ID: 3838827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hereditary protein C deficiency with stanozolol.
    Broekmans AW; Conard J; van Weyenberg RG; Horellou MH; Kluft C; Bertina RM
    Thromb Haemost; 1987 Feb; 57(1):20-4. PubMed ID: 3590078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large intracardiac thrombus in a patient with steroid-responsive nephrotic syndrome.
    Tamura H; Oyamada J; Shimada S; Okazaki M; Tsuchida S; Toyono M; Takahashi T
    Nephrology (Carlton); 2016 Jan; 21(1):72. PubMed ID: 26693847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.